Trial news

On the 29th of November 2023, at the MS Research conference in Perth, Australia, it was announced that people with progressive MS in Australia will be able to join Platypus (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis). Platypus is an extension of Octopus and is funded by MS Western Australia and MS Australia. For more information, visi ...

A four-part series about the Octopus trial has been produced by the Trial Talk podcast at the MRC Clinical Trials Unit at UCL. The episodes explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS. You can listen to the episodes in SoundCloud, Spotify, Google podcasts and Apple podcasts. ...

As previously reported in February by Susan Scott, one of our patient representatives, Octopus had a presence at the International Advisory Committee meeting on Clinical Trials in MS in Toronto in December 2022. Following this meeting, a publication has been drafted and published on Participant involvement in Octopus.  This is alongside four further publications published foll ...

The next version of the Octopus Protocol and associated documents has been released for trial teams today for approval at their sites and implementation from 2nd October (when approved).  The notification has been sent to all Principal investigators, first point of contacts and pharmacy representatives. If an Octopus site did not receive it and would like further information, p ...

We are delighted to welcome two more Octopus hospital sites, one at Belfast City Hospital and another at University Hospital Dorset, at Poole. We look forward to working with you! For the full list of hospitals where Octopus is operating, please see the Octopus Site page. ...